Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure

Journal of the American College of Cardiology

Volumn 51, Issue 24, 2008, Pages 2329-2335

  Nishii, Mototsugu ^a   Inomata, Takayuki ^a   Takehana, Hitoshi ^a   Naruke, Takashi ^a   Yanagisawa, Tomoyoshi ^a   Moriguchi, Masahiko ^a   Takeda, Sadao ^a   Izumi, Tohru ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONGESTIVE CARDIOMYOPATHY; DISCRIMINANT ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONISCHEMIC DILATED CARDIOMYOPATHY; OUTPATIENT; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; BIOLOGICAL MARKERS; CARDIOMYOPATHY, DILATED; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; STROKE VOLUME;

EID: 44649155766     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.11.085     Document Type: Article

References (31)

1. Krumholz H.M., Parent E.M., Tu N., et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med 157 (1997) 99-104
2. Haldeman G.A., Groft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: national hospital discharge survey 1985-1995. Am Heart J 137 (1999) 352-360
3. Cowie M.R., Fox K.F., Wood D.A., et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J 23 (2002) 877-885
4. Yoshimura M., Yasue H., Okamura K., Ogawa H., Jougasaki M., and Kukoyama M. Different secretion pattern of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87 (1993) 464-469
5. Yasue H., Yoshimura M., Sumida H., et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
6. Maisel A.S., Krishnaswamy P., Nowak R.M., et al., Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
7. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of a rapid B-natriuretic peptide (BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209
8. Cheng V.L., Kazanegra R., Garcia A., et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol 37 (2001) 386-391
9. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
10. Verdiani V., Nozzoli C., Bacci F., et al. Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail 7 (2005) 566-571
11. Hunt S.A., Baker D.W., Chin M.H., et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 38 (2001) 2101-2113
12. Kadish A., Dyer A., Daubert J.P., et al., Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
13. Wang T.J., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
14. Fonarow G.C., Peacock W.F., Phillips C.O., Givertz M.M., Lopatin M., and ADHERE Scientific Advisory Committee and Investigators. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 1943-1950
15. Rathore S.S., Masoudi F.A., Wang Y., et al. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J 152 (2006) 371-378
16. Hogenhuis J., Voors A.A., Jaarsma T., Hillege H.L., Hoes A.W., and van Veldhuisen D.J. Low prevalence of B-type natriuretic peptide levels <100 pg/ml in patients with heart failure at hospital discharge. Am Heart J 151 (2006) 1012-1015
17. Bourassa M.G., Gurne O., Bangdiwala S.I., et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol 22 Suppl A (1993) 14-19
18. Ruta J., Ptaszynski P., Maciejewski M., Goch J.H., and Chizynski K. Effect of low doses of metoprolol, bisoprolol and carvedilol on mortality in patients with left ventricular dysfunction after acute myocardial infarction. [in Polish]. Wiad Lek 59 (2006) 649-653
19. Waagstein F., Caidahl K., Wallentin I., Bergh C.H., and Hjaimarson A. Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol. Circulation 80 (1989) 551-563
20. Packer M., Bristow M.R., Cohn J.N., et al., U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334 (1996) 1349-1355
21. The MERIT-HF Study Group. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 353 (1999) 2001-2007
22. Di Lenarda A., Sabbadini G., Salvatore L., et al., the Heart-Muscle Disease Study Group. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. J Am Coll Cardiol 33 (1999) 1926-1934
23. Wojtkowska I., Sobkowicz B., Musial W.J., and Kozuch M. Persistent atrial fibrillation as a prognostic factor of outcome in patients with advanced heart failure. [in Polish]. Kardiol Pol 64 (2006) 777-783
24. Olshausen K., Schafer A., Mehmel H.C., Schwarz F., Senges J., and Kubler W. Ventricular arrhythmia in idiopathic dilated cardiomyopathy. Br Heart J 51 (1984) 195-201
25. De Lemos J.A., McGuire D.K., and Drazner M.H. B-type natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-322
26. Doughty R.N., Whalley G.A., Gamble G., MacMahon S., Sharpe N., and on behalf of the Australia-New Zealand Heart Failure Research Collaborative Group. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J Am Coll Cardiol 29 (1997) 1060-1066
27. Hoit B.D., Shao Y., Gabel M., and Walsh R.A. In vivo assessment of left atrial contractile performance in normal and pathological conditions using a time-varying elastance model. Circulation 89 (1994) 1829-1838
28. Dernellis J.M., Stefanadis C.I., Zacharoulis A.A., and Toutouzas P.K. Left atrial mechanical adaptation to long-standing hemodynamic loads based on pressure-volume relations. Am J Cardiol 81 (1998) 1138-1143
29. Weener G.S., Schaefer C., Dirks R., Figulla H.C., and Kreuzer H. Prognostic value of Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy. Am J Cardiol 73 (1994) 792-798
30. Giannuzzi P., Temporelli P.L., Bosimini E., et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol 28 (1996) 383-390
31. Jourdain P., Jondeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study. J Am Coll Cardiol 49 (2007) 1733-1739